Bhutan gives 300K doses of AstraZeneca jabs to Nepal


Kathmandu, Aug 6 | Nepal on Friday received 300,000 doses of the AstraZeneca Covid-19 vaccines supplied by Bhutan, which comes as a relief for the senior citizens who are awaiting a second jab.

“We received the consignment this morning,” said R.P. Biccha, Director General at Nepal’s Department of Health Services.

After completing the inoculation of 90 per cent of its population, Bhutan had a surplus of 300,000 doses of the AstraZeneca vaccines.

Before delivering the doses, the Bhutanese government, AstraZeneca and Kathmandu reached a tripartite agreement where Nepal had committed that it will return them once it will have surplus doses.

The vaccine package was received by senior official from the Foreign and Health Ministries at the Tribhuvan International Airport in Kathmandu.

Around 1.4 million people aged 65 and above in Nepal who were given the first shots of Covishield, the AstraZeneca type vaccine manufactured by the Serum Institute of India, in the second week of March, have been waiting for their second doses.

However, the government has not been able to secure any additional AstraZeneca doses.

Nepal has so far has received 9.782 million doses of vaccine.

Of the total, 4 million doses were procured by the government from Vero Cell from China and 1 million doses of Covishield from India.

India has provided 1.1 million doses of Covishield under grant assistance.

Over 1.5 million doses of Johnson & Johnson vaccine arrived from the US, under COVAX, in Nepal on July 12

China, which has already donated 1.8 million doses of Vero Cell, developed and manufactured by the state-owned Sinopharm, has promised an additional 1.6 million doses to Nepal.

Source: IANS

Next Story

Weekly Technical Share Market Outlook

Weekly Technical Share Market Outlook

The Indian market recovered with modest gain against the resilient global cues. Throughout the week, Sensex traded in a narrow range following an uneven move. Sensex ended at 54884.66 gaining 558 points or 1.03 percent while Nifty settled at 16352.45 with 86 points or 0.53 percent on a weekly basis. While Banknifty ended at 35613.30 levels with strong bounce with an upside of 3.90 percent in a week.

sharemarket weekly updates bhaskarlive

INDIA VIX has cooled off during the week with 7.01 percent and has settled at 21.48 levels. Investors and traders may watch out key events such as the RBI meet in the second week as well as the US Fed meeting likely to be on 14-15 June for monthly expiry. As corporate results are likely to end soon stocks would expect less volatility in upcoming days. In Nifty stocks, HDFCLIFE gained 9.61 percent while DIVISLAB shed 18.41 percent in a week. Sectorally Nifty Finance saw the highest gains of 4.32 percent followed by the Nifty Auto with 3.26 percent. On the flip side Nifty Pharma, Energy, Realty and PSE lose more than 3 percent each on a weekly basis. However Midcap gained 0.77 percent while Smal lcap dropped by 3.42 percent.

Technically, Nifty has formed a bullish candle on the weekly chart with a long tail suggesting strong support around 15900 levels, while on the upside 16800 may act as strong resistance. Index has taken support from the previous horizontal line & closed above 21-days Simple Moving Averages that indicates further pullback rally in the near term.

Indicators such as RSI remained in the neutral zone while MACD suggest some positive cross over observed in daily time frame suggest some sign of reversal. Coming to the OI Data, on the call side the highest OI witnessed was 16500 followed by 16800 strike prices while on the put side, the highest OI was at 16000 strike price. Overall, Nifty is having support at 16000 mark while on the upside 16500 followed by 16750 may act as an immediate resistance. While Bank nifty has support around 34300 while resistance is placed at 36800 on weekly chart.

Om Mehera
Research Associates
Choices Broking

Souce: Choice India


Please enter your comment!
Please enter your name here